Inactive Instrument

MediRatt AB Share Price Swiss Exchange

Equities

MEDR.B

SE0003656834

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
- SEK - Intraday chart for MediRatt AB

Financials

Sales 2021 375K 35.63K 2.97M Sales 2022 729K 69.27K 5.78M Capitalization 24.14M 2.29M 191M
Net income 2021 -36M -3.42M -285M Net income 2022 -23M -2.19M -182M EV / Sales 2021 116 x
Net cash position 2021 13.74M 1.31M 109M Net Debt 2022 2.3M 218K 18.21M EV / Sales 2022 36.3 x
P/E ratio 2021
-1.03 x
P/E ratio 2022
-0.99 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 13.76%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 39 01/19/01
Director of Finance/CFO - 09/20/09
Chief Tech/Sci/R&D Officer 33 01/21/01
Members of the board TitleAgeSince
Chairman 82 14/13/14
Director/Board Member 71 01/19/01
Director/Board Member 49 01/21/01
More insiders
iZafe Group AB, formerly MediRatt AB, is a Sweden-based company that conducts research, development and marketing of medical products for medication and drug management. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The Company operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. It is active globally.
Calendar
More about the company